Barry D. Quart

2021

In 2021, Barry D. Quart earned a total compensation of $5.4M as Chief Executive Officer at Heron Therapeutics, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$392,000
Option Awards$2,268,479
Salary$700,000
Stock Awards$2,061,649
Other$8,700
Total$5,430,828

Quart received $2.3M in option awards, accounting for 42% of the total pay in 2021.

Quart also received $392K in non-equity incentive plan, $700K in salary, $2.1M in stock awards and $8.7K in other compensation.

Rankings

In 2021, Barry D. Quart's compensation ranked 2,360th out of 12,397 executives tracked by ExecPay. In other words, Quart earned more than 81.0% of executives.

ClassificationRankingPercentile
All
2,360
out of 12,397
81st
Division
Manufacturing
928
out of 5,492
83rd
Major group
Chemicals And Allied Products
352
out of 2,367
85th
Industry group
Drugs
305
out of 2,090
85th
Industry
Pharmaceutical Preparations
197
out of 1,537
87th

Pay ratio

Barry D. Quart's Pay$5,430,828
Median Employee's Pay$268,692
Pay Ratio

20

to 1

In 2021, the annual total compensation of Barry D. Quart was $5,430,828.

The annual total compensation of the median employee at Heron Therapeutics was $268,692.

The ratio of Barry D. Quart's pay to the pay of median employee was therefore 20 to one.

Source: SEC filing on April 25, 2022.

Quart's colleagues

We found four more compensation records of executives who worked with Barry D. Quart at Heron Therapeutics in 2021.

2021

Kimberly Manhard

Heron Therapeutics

Executive Vice President, Drug Development

2021

John Poyhonen

Heron Therapeutics

President and Chief Commercial Officer

2021

David Szekeres

Heron Therapeutics

Chief Operating Officer

2021

Lisa Peraza

Heron Therapeutics

Chief Accounting Officer

News

You may also like